Both in Pharmaceuticals
Zenas BioPharma vs Stoke Therapeutics
Over the past year ZBIO returned −11.8% and STOK returned +1.5%; their daily moves had a correlation of 0.13.
ZBIO −11.8% STOK +1.5%Growth of $1, one year, split-adjusted
| Metric | ZBIO | STOK |
|---|---|---|
| Price | $27.62 | $26.48 |
| Market cap | $1.80B | $1.71B |
| Today | −2.71% | +0.72% |
| 1 month | −2.4% | +3.4% |
| 6 months | +28.1% | −22.5% |
| Year to date | −23.9% | −16.6% |
| 1 year | −7.6% | −16.5% |
| Revenue growth (YoY) | — | −32.5% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −11145.6% | −660.8% |
| P/E (TTM) | — | — |
| Price / sales | 1,800.2× | 61.9× |
| Net cash | $346.1M | $292.8M |
| Dividend yield | — | — |
| Volatility (60d) | 55.7% | 47.8% |
| Short % of float | 40.2% | 18.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).